Clinical Trial Update: Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating timing of systemic treatment initiation in asymptomatic metastatic pancreatic cancer; results not yet disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Metastatic Pancreas Cancer | Phase 3 | Status: UNKNOWN